Chemical inhibitors of NCU-G1 can exert their inhibitory effects through various mechanisms, each targeting specific signaling pathways and kinases that are known to regulate the activity of NCU-G1. Staurosporine is a potent protein kinase inhibitor that can disrupt the phosphorylation process essential for the activity of NCU-G1. By blocking this phosphorylation, Staurosporine can prevent NCU-G1 from performing its cellular functions. Similarly, LY294002 and Wortmannin are inhibitors of PI3K, a kinase that functions upstream of NCU-G1 within important signaling cascades. Inhibition of PI3K leads to a reduction in the activity of downstream targets, including NCU-G1. SP600125 targets JNK, a kinase that influences transcription factors that regulate NCU-G1, thereby reducing the protein's activity. U0126 and PD98059 are inhibitors of MEK1/2, which are part of the MAPK/ERK pathway. This pathway is involved in the regulation of NCU-G1, and its inhibition leads to decreased function of NCU-G1.
In addition to the aforementioned inhibitors, SB203580 acts on p38 MAP kinase, another key molecule in the signaling pathways that regulate NCU-G1, resulting in the inhibition of NCU-G1's function. Rapamycin targets mTOR, a central regulator in cell growth and proliferation pathways that NCU-G1 is involved in, leading to the inhibition of NCU-G1. GF109203X inhibits protein kinase C, which is potentially involved in the phosphorylation and regulation of NCU-G1, therefore inhibiting the function of NCU-G1. PP2 inhibits Src family kinases, which are upstream regulators of NCU-G1, and their inhibition results in the decreased activity of NCU-G1. Y-27632 targets ROCK, which is involved in signaling pathways that include NCU-G1, leading to the inhibition of NCU-G1. Lastly, ZM-447439 inhibits Aurora kinases, which are believed to be involved in the regulation of pathways including NCU-G1, thus preventing NCU-G1 from fulfilling its cellular role. Each of these chemicals directly interrupts the signaling pathways and molecular functions that enable NCU-G1 to act, thereby serving as effective inhibitors of the protein's activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Inhibits multiple protein kinases, including those that phosphorylate NCU-G1, leading to functional inhibition of NCU-G1's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which is upstream of signaling pathways NCU-G1 is involved in, resulting in decreased activity of downstream proteins like NCU-G1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which, when active, can lead to activation of transcription factors that regulate NCU-G1, thereby inhibiting NCU-G1 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, part of the MAPK/ERK pathway, which is involved in the regulation of NCU-G1, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Specifically inhibits p38 MAP kinase, involved in the signaling pathways regulating NCU-G1, thereby inhibiting its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K which is involved in the regulation of NCU-G1, leading to a decrease in NCU-G1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is involved in the MAPK/ERK pathway that regulates NCU-G1, leading to inhibition of NCU-G1's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which is part of the signaling pathways that NCU-G1 is involved in, leading to functional inhibition of NCU-G1. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Inhibits protein kinase C, which is potentially involved in the phosphorylation and regulation of NCU-G1, thus inhibiting its function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Inhibits Src family kinases, which could be upstream regulators of NCU-G1, leading to the functional inhibition of NCU-G1. | ||||||